Search for: "Daubert v. Merrell Dow Pharmaceuticals, Inc." Results 81 - 100 of 292
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
14 Sep 2017, 6:00 am by Dani Alexis Ryskamp
Merrell Dow Pharmaceuticals, Inc., a Supreme Court case that changed the landscape of expert witness testimony and case preparation when it was decided in 1993. [read post]
14 Sep 2017, 6:00 am by Dani Alexis Ryskamp
Merrell Dow Pharmaceuticals, Inc., a Supreme Court case that changed the landscape of expert witness testimony and case preparation when it was decided in 1993. [read post]
27 Jul 2017, 2:00 am
MERRELL DOW PHARMACEUTICALS, INC 509 U.S. 579 (1993)KOKKONEN V. [read post]
16 Jun 2017, 7:00 am by Anjelica Cappellino
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993), the Supreme Court case upon which the standard for expert testimony is based, seeks to exclude the testimony of an expert witness that is not relevant or reliable. [read post]
13 Jun 2017, 4:00 am by Jeff Welty
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993), where the Supreme Court ruled that, under the federal evidence rules, “the trial judge must ensure that any and all scientific testimony or evidence admitted is not only relevant, but reliable” in light of several factors enumerated by the Court. [read post]
20 Apr 2017, 8:23 am by Elizabeth Kruska
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579(1993). [read post]
18 Apr 2017, 6:01 am by Anjelica Cappellino
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993), which established the governing standard of expert testimony admissibility in federal courts and the majority of state jurisdictions. [read post]
2 Mar 2017, 8:22 pm by Adam Music
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993), set the standard for admissibility of scientific expert testimony under the Federal Rules of Evidence (FRE). [read post]
6 Dec 2016, 6:01 am by Anjelica Cappellino
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993), which outlines a non-exhaustive list of factors for the courts to consider when determining the expert testimony admissibility. [read post]
6 Dec 2016, 6:01 am by Anjelica Cappellino
Merrell Dow Pharmaceuticals, Inc., 509 U.S. 579 (1993), which outlines a non-exhaustive list of factors for the courts to consider when determining the expert testimony admissibility. [read post]